Clinical studies have revealed that elevated Apoa4 concentrations correlate with attenuated inflammation in moderate CKD patients, suggesting that Apoa4 not only serves as an independent risk marker of reduced inflammation in CKD patients but also may actively participate in the pathophysiological process of CKD through its anti-inflammatory mechanisms[24]. The gene discussed is APOA4; the disease is chronic kidney disease.